Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof
The present invention discloses certain novel prodrugs of chloramphenicol or thiamphenicol, or of an analog of either, including prodrugs of pharmaceutically acceptable salts of chloramphenicol or thiamphenicol or of their analogs, including nitrogen-containing esters of both alcohol groups of such compounds. In certain embodiments these novel prodrugs are sufficiently water-soluble to serve the functions needed of a prodrug of chloramphenicol or thiamphenicol or of an analog of either. In one embodiment, a certain subclass of the compounds also possesses the hydrolytic stability needed to maintain the prodrug in solution in the subject's system until appropriate conditions exist when the prodrug can hydrolyze, releasing the active compound in question.
1. A compound having the Formula (I)
in which:
R is selected from the group consisting of
R 3 is selected from the group consisting of dichloromethyl, difluoromethyl, chlorofluoromethyl, chloromethyl, methyl, cyanomethyl, azidomethyl, and aminomethyl; and
—O—C(═O)-A a -L l -M m -X x —Y is selected from the group consisting of:
wherein n is an integer from 2-6 and R′ is H, Me or Et; and
wherein n is an integer from 1 to 6 and R′ is Me or Et;
and pharmaceutically acceptable salts thereof.
2. A pharmaceutical composition comprising a therapeutically effective amount of a compound or salt according to claim 1 and a pharmaceutically acceptable diluent or carrier.
3. A composition according to claim 2 further comprising an effective amount of one or more additional medicinal agents.
4. A composition according to claim 3 in which the one or more additional medicinal agents are selected from microbiocides, anthelmintics, ecto- and endoparasticides, anti-fluke agents, anti-inflammatories, anti-infectives, hormones, dermatological preparations, including antiseptics and disinfectants, and immunobiologicals including vaccines and antisera.
5. A method of treating a microbial infectious disease or disorder in a subject comprising administering to said subject a therapeutically effective amount of a compound according to claim 1 .
6. A method of treating a microbial infectious disease or disorder in a subject comprising administering to said subject a therapeutically effective amount of a composition according to claim 2 .